PYC 5.26% 20.0¢ pyc therapeutics limited

Ann: Core patent granted in Australia , page-8

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 5,380 Posts.
    lightbulb Created with Sketch. 692
    my view if it matters is that the original patented libraries were based on genetically diverse organisms blah blah that were highly stable etc due to evolution, but it would appear may not neccesarily have been that good at penetrating human cells which was the whole point. The major breakthrough now it appears is we have patented a library that includes peptides derived from virus or viral materials, which already have obvious and proven abiliy to penetrate human cells. To me it seems any major descovery should be more likely using phylomers derived from these types of cells as they have known cell penetrating ability. All the questions on the original phylomer library seem to be around cell penetration ability with or without payload, and around theyre effective half life while in contact with human blood etc. Surely to have a patent on phylomees derived from viral factors is a najor step for the libraries, but would be a lot more use if we had 20 mil in the bank.
    Re the SP could this be the final test of 2.5 c as resistance now before the next massive dump?
 
watchlist Created with Sketch. Add PYC (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
0.010(5.26%)
Mkt cap ! $933.2M
Open High Low Value Volume
19.0¢ 20.0¢ 18.8¢ $963.9K 4.978M

Buyers (Bids)

No. Vol. Price($)
1 2692 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 445208 3
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.